A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy Volunteers

NCT02877264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: vapendavir 132 mg capsule
DRUG: vapendavir 264 mg tablet
DRUG: vapendavir 24 mg/mL oral suspension

Sponsor

Aviragen Therapeutics